Sarepta Therapeutics, Inc. SRPTW Company Overview Stock

New Post Public Reply Private Reply Replies (0) Message Board

Sep 13, 2013 at 3:54 PM

Sarepta Therapeutics, Inc. SRPTW Company Overview

Stock Message Board http://investorshangout.com/search?q=SRPTW&am...mp;yt1=Go!

Sarepta Therapeutics, Inc. SRPTW Current Price and Quotes
Last Price 1.75
Previous Close 1.75 Open N/A
Daily Range N/A - N/A 52wk Range 2.50 - 0.40
Volume 0 Dividend N/A
Average Vol (3m) 48,507 Yield N/A
Sarepta Therapeutics, Inc. SRPTW
Company Information

215 First Street
Suite 007
Cambridge, MA 02142

Website: http://www.antivirals.com
Phone: 857-242-3700
Email: avi@avibio.com

Sarepta Therapeutics, Inc. SRPTW
Sarepta Therapeutics, Inc. SRPTW
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Latest Report Jun 30, 2013 10-Q
CIK 0000873303
Fiscal Year End 1/31
OTC Marketplace Grey Market
Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts

Christopher Garabedian President, CEO
Edward M. Kaye Senior VP, Chief Med. Officer
Sandesh Mahatme Senior VP, CFO
Michael Jacobsen VP, Fin.
Effie Toshav General Counsel
Melinda Miles Controller
Erin Cox IR
Company Directors

Not Available
Company Notes

Note = Domicile changed from Oregon to Delaware in June of 2013
Formerly=AVI BioPharma, Inc. until 7-2012
Formerly=AntiVirals, Inc. until 8-98
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Sarepta Therapeutics, Inc. SRPTW
SRPTW Security Details Other Company Securities

Share Structure

Market Value1 $193,184,492 a/o Sep 12, 2013
Shares Outstanding 110,391,138 a/o Aug 28, 2012
Float Not Available
Authorized Shares Not Available
Par Value No Par Value
Shareholders

Shareholders of Record Not Available
Security Notes

Capital Change=shs decreased by 1 for 6 split Ex-date=07/25/2012.
Capital Change=shs increased by 6 for 1 split. Payable upon surrender.. Ex-date=08/28/2012.
Short Selling Data

Short Interest 1,080 (8%)
Aug 30, 2013
Significant Failures to Deliver No
Transfer Agent(s)

Sarepta Therapeutics, Inc. SRPTW Recent News

Sept 4, 2013 Critical Alerts For Exxon Mobil, Home Depot, JC Penney, Southern Copper, and Sarepta Therapeutics Released By InvestorsObserver
Aug 26, 2013 Sarepta Therapeutics to Present Company Overview at Upcoming Conferences
Aug 19, 2013 Technical Study: ACADIA Pharma Inc., Medivation Inc., Sarepta Therapeutics Inc., and Cell Therapeutics Inc.
Aug 8, 2013 Earnings Transcripts of Sarepta Therapeutics, LINN Energy and Royal Gold, Inc. Now Available
Aug 8, 2013 Sarepta Therapeutics Announces Publication of Eteplirsen Clinical Study Results in the Annals of Neurology
Aug 8, 2013 Sarepta Therapeutics Announces Second Quarter 2013 Financial Results and Recent Corporate Developments
Jul 30, 2013 Critical Alerts For Citigroup, JPMorgan, Time Warner Cable, TakeTwo Interactive, and Sarepta Therapeutics Released By InvestorsObserver
Jul 25, 2013 BBRY, MNKD, IRBT and SRPT added to NASDAQ Active Stock Watch List at GSR
Jul 25, 2013 Reveal Insider Trading with Earnings for Yahoo, JPMorgan Chase, eBay, Walter Energy, Caterpillar, and Sarepta Therapeutics
Jul 25, 2013 Sarepta Therapeutics to Announce Second Quarter 2013 Financial Results and Corporate Update on August 8, 2013

1
2
next >

Sarepta Therapeutics, Inc. SRPTW Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 37,329 46,990 29,420 17,585
Cost of Revenue - - - -
Gross Profit 37,329 46,990 29,420 17,585
Operating Expenses

Research and Development 52,402 66,862 35,972 24,396
Sales, General and Admin. 14,630 16,055 14,382 8,696
Non-Recurring Items - - - -
Other - - - -
Operating Income (29,703) (35,927) (20,934) (15,507)
Income From Continuing Operations

Add'l Income/Expense Items (91,584) 33,609 (11,243) (9,198)
Earnings Before Interest and Tax (121,287) (2,318) (32,177) (25,159)
Interest Expense - - - -
Earnings Before Tax (121,287) (2,318) (32,177) (25,159)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (121,287) (2,318) (32,177) (25,159)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (121,287) (2,318) (32,177) (25,159)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (121,287) (2,318) (32,177) (25,159)

SRPTW Sarepta Therapeutics, Inc. Research DD Guide

SRPTW Sarepta Therapeutics, Inc. Stock Message Board http://investorshangout.com/search?q=SRPTW&am...mp;yt0=Go!
SRPTW Sarepta Therapeutics, Inc. Stock Quote http://www.otcmarkets.com/stock/SRPTW/quote
SRPTW Sarepta Therapeutics, Inc. Stock Chart http://www.otcmarkets.com/stock/SRPTW/chart
SRPTW Sarepta Therapeutics, Inc. Company Info http://www.otcmarkets.com/stock/SRPTW/company-info
SRPTW Sarepta Therapeutics, Inc. Recent News http://www.otcmarkets.com/stock/SRPTW/news
SRPTW Sarepta Therapeutics, Inc. Financials http://www.otcmarkets.com/stock/SRPTW/financials
SRPTW Sarepta Therapeutics, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/SRPTW/filings
SRPTW Sarepta Therapeutics, Inc. Short Sales http://www.otcmarkets.com/stock/SRPTW/short-sales
SRPTW Sarepta Therapeutics, Inc. Insider Disclosure http://www.otcmarkets.com/stock/SRPTW/insider-transactions
SRPTW Sarepta Therapeutics, Inc. Research Reports http://www.otcmarkets.com/stock/SRPTW/research
SRPTW Sarepta Therapeutics, Inc. Summary http://finance.yahoo.com/q?s=SRPTW
SRPTW Sarepta Therapeutics, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=SRPTW+Historical+Prices
SRPTW Sarepta Therapeutics, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=SRPTW
SRPTW Sarepta Therapeutics, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=SRPTW+Basic+Chart
SRPTW Sarepta Therapeutics, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=SRPTW+Basic+Tech.+Analysis
SRPTW Sarepta Therapeutics, Inc. Headlines http://finance.yahoo.com/q/h?s=SRPTW+Headlines
SRPTW Sarepta Therapeutics, Inc. Press Releases http://finance.yahoo.com/q/p?s=SRPTW+Press+Releases
SRPTW Sarepta Therapeutics, Inc. Company Profile http://finance.yahoo.com/q/pr?s=SRPTW+Profile
SRPTW Sarepta Therapeutics, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=SRPTW+Key+Statistics
SRPTW Sarepta Therapeutics, Inc. Industry http://finance.yahoo.com/q/in?s=SRPTW+Industry
SRPTW Sarepta Therapeutics, Inc. Major Holders http://finance.yahoo.com/q/mh?s=SRPTW+Major+Holders
SRPTW Sarepta Therapeutics, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=SRPTW+Insider+Transactions
SRPTW Sarepta Therapeutics, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=SRPTW+Insider+Roster
SRPTW Sarepta Therapeutics, Inc. Income Statement http://finance.yahoo.com/q/is?s=SRPTW
SRPTW Sarepta Therapeutics, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=SRPTW
SRPTW Sarepta Therapeutics, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=SRPTW+Cash+Flow&annual
SRPTW Sarepta Therapeutics, Inc. Nasdaq http://www.nasdaq.com/symbol/SRPTW
SRPTW Sarepta Therapeutics, Inc. Market Watch http://www.marketwatch.com/investing/stock/SRPTW
SRPTW Sarepta Therapeutics, Inc. Bloomberg http://www.bloomberg.com/quote/SRPTW:US
SRPTW Sarepta Therapeutics, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=SRPTW
SRPTW Sarepta Therapeutics, Inc. Bussinessweek http://investing.businessweek.com/research/st...cker=SRPTW
SRPTW Sarepta Therapeutics, Inc. Barchart http://www.barchart.com/quotes/stocks/SRPTW
SRPTW Sarepta Therapeutics, Inc. OTC Short Report http://otcshortreport.com/index.php?index=SRPTW
SRPTW Sarepta Therapeutics, Inc. Investopedia http://www.investopedia.com/markets/stocks/SRPTW/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sodium-Ion Tech Showcased by Aeson Power in Melbourne

A Shock to the System: Sodium-Ion's Rising Star If you're tired of hearing about lithium, Aeson Power just gave us a much-needed jolt at All Energy Australia 2026. This isn't just some new fad—they've proven the real-world chops of sodium-ion technology across energy storage and automotive platforms. At the Melbourne show, they laid out their goods, showing how this...

Stora Enso Plans Bold Demerger; Bergslagets Skogar to List

Stora Enso's Strategic Split: Bold Move or Risky Bet? There's something almost audacious about Stora Enso's decision to separate Bergslagets Skogar into its own publicly listed company. The board has given this demerger plan the green light, aiming to unravel a more refined operation out of Stora Enso's labyrinthine portfolio. It's a move that should have the suits on...

Reducto Office Transforms Document Editing with AI

AI Meets Full-Fidelity Document Editing Gone are the days when AI could only analyze documents. With Reducto Office's latest plugin, the AI's stepping right into the editing game. For free, they say! Built smack-dab into ChatGPT and Codex, this plugin lets users work their AI magic on Word docs, PowerPoint presentations, and Excel spreadsheets. And the kicker? You can see...

The Sift: Slickdeals’ Game-Changing Black Friday Tool

Revolutionizing Black Friday Planning Off we go, diving headfirst into the chaotic whirlpool that is Black Friday shopping. Slickdeals seems to think they’ve got the golden ticket with The Sift, and I can't say they're wrong. Instead of the traditional paper ad scans we've been sifting through since the dawn of time, The Sift brings all announced deals into one...

Gooru AI Unveils Platform to Scale Human Expertise

A New Wave of AI-Powered Solutions Hot off the press, Gooru AI's recent shindig in the heart of Dallas aimed to showcase something they call 'Digital Goorus.' Now that might sound like a newage tech gimmick but peel back the layers and you find an ambitious attempt to let folks spread their smarts without having to be everywhere all at once. Imagine being able to crack...

Bybit Unveils Platform Vision at HK FinTech Week

Bybit's Strategic Participation at HK FinTech Week Here’s what’s got everyone buzzing: Bybit is stepping onto the big stage at the Hong Kong FinTech Week 2026. We're talking about the crème de la crème of fintech gatherings, where the sharpest minds of the financial world mingle, munch, and strategize under the buzzing neon of Hong Kong. Bybit's involvement is no...

New Insurance Rules Limit Public Input Amid Controversy

Insurance Rules Change the Game, Yet Again When the bureaucracy tightens its grip, consumers often pay the price. California's recent twist in insurance regulations does just that, taking a red pen to public involvement and paving the road for insurers to hike rates with less interference. A Peek Behind the Curtain This new maneuver by the Department of Insurance...

CNOOC Limited's 2026 Surge: New Projects, New Heights

Production Peaks and New Discoveries Over in the bustling corridors of oil and gas, CNOOC Limited is making some strong waves. Why? Because they’ve hit historical peaks in production in the first three quarters of 2026. We’re talking about a net production of 593.7 million barrels of oil equivalent. That’s a 2.7% climb from last year. Seems like CNOOC is really...

Anguilla Culinary Festival 2027: A Feast Beyond Food

A Culinary Quest in the Caribbean Imagine this: a culinary pilgrimage where the Caribbean’s essence is served on a plate. The Anguilla Culinary Experience (ACE), set for April 28 through May 2, 2027, isn't just about stretching waistbands. It’s about embracing the spirit and flavors of Anguilla, one of the world's cherished culinary hotspots. Cooking with Purpose ACE...

California Housing Affordability Stagnant as Rates Rise

Numbers Tell the Story Get this: California's housing market's as sticky as day-old gum on a hot sidewalk. Despite a dip in home prices, affordability just won't budge. The California Association of REALTORS® (C.A.R.) says 19% of households could afford a median-priced home at $894,630, exactly like last quarter and even a year back. Not a flicker of change. Quirky it...